MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
24 val.
Dabar
Min
2.68
Max
2.84
Rekomendacijos | Pirkti |
---|---|
12 mėnesių prognozė | +417.86% upside |
Kitas uždarbis | 2025-11-12 |
---|
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-10-01 15:07; UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Skaityti
2025-03-10 02:12; UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Skaityti
2025-03-10 02:12; UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
2025-03-10 02:06; UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 14.5 USD 417.86%
Aukščiausias 17 USD
Žemiausias 12 USD
Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fortress Biotech Inc kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Pirkti
2 ratings
2
Pirkti
0
Laikyti
0
Parduoti
Remiantis 2 analitikų, pateikusių Fortress Biotech Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
$